Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (111)	1/24/1999 10:48:00 AM
From: Rick Costantino	Read Replies (1) \| Respond to of 1834

I have been watching this one for a while, and it looks promising. I decided to take a small position last week. It seems to me as if they should have news regarding several of their trials which was supposed to already be out. Any small company in this area seems worth a chance since there are large unmet markets for neurological disorders. There may be some downside here, but I feel that it is limited compared to the potential upside. NBIX seems to have a number of interesting drugs in development, good partners for collaborations, and a good balance sheet. Rick